Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.
Adolescent School Girls
Human Papilloma Virus Vaccine
Lira City
Uptake
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
08 Jul 2023
08 Jul 2023
Historique:
received:
24
01
2023
accepted:
26
06
2023
medline:
10
7
2023
pubmed:
8
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
Cervical cancer is the most common Human Papilloma Virus (HPV)-related disease among women. Since 2008, HPV vaccination has been routinely recommended for pre-adolescent and adolescent girls in Uganda as the primary preventive measure for cervical cancer. However, in Uganda, most especially in Lira district, there is limited literature on HPV vaccination uptake and associated factors among girls aged 9-14years. This study assessed the uptake of HPV vaccine and associated factors among in-school girls aged 9-14 years in Lira City, northern Uganda. A cross-sectional study was conducted among 245 primary school girls aged 9-14 years in Lira City, northern Uganda. Multistage sampling technique was used to sample eligible participants and data was collected using interviewer administered questionnaire. Data was analysed using SPSS version 23.0. Descriptive statistics and multivariate logistic regression at 95% level of significance were used to identify the level of HPV vaccine uptake and predictors respectively. HPV vaccination uptake was at 19.6% (95% CI,14.8-25.1) among the school girls aged 9-14 years in Lira City, northern Uganda. The mean age of the girls was 12.11 (± 1.651) years. Predictors that were independently associated with HPV vaccine uptake included; recommendation from health worker [aOR 9.09, 95% CI (3.19-25.88), P ≤ 0.001], taught about cervical cancer at school [aOR,12.56, 95% CI (4.60-34.28), P ≤ 0.001], and exposure to outreach clinics [aOR, 4.41, 95% CI (1.37-14.19), P = 0.013]. The study found that one in five of the school girls in Lira City, northern Uganda. received HPV vaccine. Girls who were taught about cervical cancer at school, exposure to outreach clinics and received health worker recommendation had more odds of receiving HPV vaccine than their counter parts. The Ministry of Health should strengthen school based cervical cancer education, awareness raising about HPV vaccination and health worker recommendations to improve HPV vaccine uptake among school girls in Uganda.
Sections du résumé
BACKGROUND
BACKGROUND
Cervical cancer is the most common Human Papilloma Virus (HPV)-related disease among women. Since 2008, HPV vaccination has been routinely recommended for pre-adolescent and adolescent girls in Uganda as the primary preventive measure for cervical cancer. However, in Uganda, most especially in Lira district, there is limited literature on HPV vaccination uptake and associated factors among girls aged 9-14years. This study assessed the uptake of HPV vaccine and associated factors among in-school girls aged 9-14 years in Lira City, northern Uganda.
METHODS
METHODS
A cross-sectional study was conducted among 245 primary school girls aged 9-14 years in Lira City, northern Uganda. Multistage sampling technique was used to sample eligible participants and data was collected using interviewer administered questionnaire. Data was analysed using SPSS version 23.0. Descriptive statistics and multivariate logistic regression at 95% level of significance were used to identify the level of HPV vaccine uptake and predictors respectively.
RESULTS
RESULTS
HPV vaccination uptake was at 19.6% (95% CI,14.8-25.1) among the school girls aged 9-14 years in Lira City, northern Uganda. The mean age of the girls was 12.11 (± 1.651) years. Predictors that were independently associated with HPV vaccine uptake included; recommendation from health worker [aOR 9.09, 95% CI (3.19-25.88), P ≤ 0.001], taught about cervical cancer at school [aOR,12.56, 95% CI (4.60-34.28), P ≤ 0.001], and exposure to outreach clinics [aOR, 4.41, 95% CI (1.37-14.19), P = 0.013].
CONCLUSION
CONCLUSIONS
The study found that one in five of the school girls in Lira City, northern Uganda. received HPV vaccine. Girls who were taught about cervical cancer at school, exposure to outreach clinics and received health worker recommendation had more odds of receiving HPV vaccine than their counter parts. The Ministry of Health should strengthen school based cervical cancer education, awareness raising about HPV vaccination and health worker recommendations to improve HPV vaccine uptake among school girls in Uganda.
Identifiants
pubmed: 37420225
doi: 10.1186/s12905-023-02511-z
pii: 10.1186/s12905-023-02511-z
pmc: PMC10329291
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
362Informations de copyright
© 2023. The Author(s).
Références
BMJ Open. 2021 Sep 2;11(9):e052016
pubmed: 34475188
Pan Afr Med J. 2018 Nov 15;31:184
pubmed: 31086634
Asian Pac J Cancer Prev. 2020 Sep 01;21(9):2799-2804
pubmed: 32986383
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Hum Vaccin Immunother. 2019;15(7-8):1962-1969
pubmed: 30633598
Afr Health Sci. 2015 Mar;15(1):33-41
pubmed: 25834528
Glob Health Sci Pract. 2018 Dec 27;6(4):629-634
pubmed: 30459216
PLoS One. 2021 Jun 29;16(6):e0253735
pubmed: 34185805
Hum Vaccin Immunother. 2021 Feb 1;17(2):451-456
pubmed: 32643527
PLoS One. 2022 Jun 9;17(6):e0269655
pubmed: 35679304
PLoS One. 2022 Aug 25;17(8):e0267617
pubmed: 36006961
BMC Womens Health. 2020 Jul 13;20(1):145
pubmed: 32660461
Int J Environ Res Public Health. 2022 May 07;19(9):
pubmed: 35565089
BMC Public Health. 2023 Mar 14;23(1):486
pubmed: 36918854
Prev Med. 2021 Mar;144:106399
pubmed: 33388322
JAMA. 2014 Nov 12;312(18):1920-1
pubmed: 25387190
BMC Public Health. 2020 Jan 31;20(1):142
pubmed: 32005202
BMC Public Health. 2020 Feb 4;20(1):171
pubmed: 32019543
PLoS One. 2022 Jul 13;17(7):e0271237
pubmed: 35830389